• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.82% Nasdaq Up 2.46%

    DepoMed Inc. (DEPO)

    -NasdaqGS
    26.81 Up 0.73(2.80%) Sep 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:26.08
    Open:26.47
    Bid:24.12 x 100
    Ask:29.32 x 100
    1y Target Est:31.50
    Beta:1.79246
    Earnings Date:Nov 3 - Nov 9 (Est.)
    Day's Range:25.83 - 26.99
    52wk Range:13.47 - 33.74
    Volume:980,919
    Avg Vol (3m):1,879,280
    Market Cap:1.62B
    P/E (ttm):24.66
    EPS (ttm):1.09
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    DEPOUp 2.80%1.62B
    MRKUp 0.86%149.23B
    PFEUp 1.95%197.17B

    Key Statistics

    Forward P/E (1 yr):18.88
    P/S (ttm):4.22
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.61
    Quarterly EPS Est (Sep-15) :0.20
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):1.47

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; CAM... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback